Uterine NK Cells Regulate Endometrial Bleeding in Women and Are Suppressed by the Progesterone Receptor Modulator Asoprisnil

被引:72
|
作者
Wilkens, Julia [1 ]
Male, Victoria [2 ]
Ghazal, Peter [3 ]
Forster, Thorsten [3 ]
Gibson, Douglas A. [1 ]
Williams, Alistair R. W. [1 ]
Brito-Mutunayagam, Savita L. [1 ]
Craigon, Marie [3 ]
Lourenco, Paula [1 ]
Cameron, Iain T. [4 ]
Chwalisz, Kristof [5 ]
Moffett, Ashley [2 ]
Critchley, Hilary O. D. [1 ]
机构
[1] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland
[2] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[3] Univ Edinburgh, Div Pathway Med, Edinburgh EH16 4SB, Midlothian, Scotland
[4] Univ Southampton, Fac Med, Southampton SO17 1BJ, Hants, England
[5] Abbott Labs, Abbott Pk, IL 60064 USA
基金
英国惠康基金; 英国医学研究理事会;
关键词
NATURAL-KILLER-CELLS; T-CELLS; EXPRESSION; IL-15; PROLIFERATION; TROPHOBLAST; INTERLEUKIN-15; LEIOMYOMATA; MORPHOLOGY; LEUKOCYTES;
D O I
10.4049/jimmunol.1300958
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Uterine NK cells (uNK) play a role in the regulation of placentation, but their functions in nonpregnant endometrium are not understood. We have previously reported suppression of endometrial bleeding and alteration of spiral artery morphology in women exposed to asoprisnil, a progesterone receptor modulator. We now compare global endometrial gene expression in asoprisnil-treated versus control women, and we demonstrate a statistically significant reduction of genes in the IL-15 pathway, known to play a key role in uNK development and function. Suppression of IL-15 by asoprisnil was also observed at mRNA level (p < 0.05), and immunostaining for NK cell marker CD56 revealed a striking reduction of uNK in asoprisnil-treated endometrium (p < 0.001). IL-15 levels in normal endometrium are progesterone-responsive. Progesterone receptor (PR) positive stromal cells transcribe both IL-15 and IL-15RA. Thus, the response of stromal cells to progesterone will be to increase IL-15 trans-presentation to uNK, supporting their expansion and differentiation. In asoprisnil-treated endometrium, there is a marked downregulation of stromal PR expression and virtual absence of uNK. These novel findings indicate that the IL-15 pathway provides a missing link in the complex interplay among endometrial stromal cells, uNK, and spiral arteries affecting physiologic and pathologic endometrial bleeding.
引用
收藏
页码:2226 / 2235
页数:10
相关论文
共 50 条
  • [1] Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leiomyomata
    Chwalisz, K
    DeManno, D
    Garg, R
    Larsen, L
    Mattia-Goldberg, C
    Stickler, T
    SEMINARS IN REPRODUCTIVE MEDICINE, 2004, 22 (02) : 113 - 119
  • [2] The history and use of the progesterone receptor modulator ulipristal acetate for heavy menstrual bleeding with uterine fibroids
    Bouchard, Philippe
    Chabbert-Buffet, Nathalie
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2017, 40 : 105 - 110
  • [3] Effect of a Selective Progesterone Receptor Modulator on Induction of Apoptosis in Uterine Fibroids In Vivo
    Horak, Petr
    Mara, Michal
    Dundr, Pavel
    Kubinova, Kristyna
    Kuzel, David
    Hudecek, Robert
    Chmel, Roman
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2012, 2012
  • [4] 17-Estradiol induces proliferation of endometrial NK cells (CD56+) in postmenopausal women
    Sho, T.
    Hachisuga, T.
    Koi, C.
    Kurita, T.
    Kagami, S.
    Kawagoe, T.
    Matsuura, Y.
    Yoshimura, K.
    Hisaoka, M.
    CLIMACTERIC, 2017, 20 (06) : 571 - 576
  • [5] Platelet-derived growth factor BB is reduced in endometrial endothelial cells of women with abnormal uterine bleeding-endometrial disorder
    Shivhare, Sourima Biswas
    Lu, Qinsheng
    Sun, Dingqian
    Hou, Huomei
    Bulmer, Judith N.
    Innes, Barbara A.
    Hapangama, Dharani K.
    Lash, Gendie E.
    REPRODUCTIVE BIOMEDICINE ONLINE, 2022, 45 (03) : 531 - 543
  • [6] Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate
    Donnez, Jacques
    Donnez, Olivier
    Dolmans, Marie-Madeleine
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (12) : 1679 - 1686
  • [7] The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells
    Luo, Xia
    Yin, Ping
    Coon, John S.
    Cheng, You-Hong
    Wiehle, Ronald D.
    Bulun, Serdar E.
    FERTILITY AND STERILITY, 2010, 93 (08) : 2668 - 2673
  • [8] Functional evidence for two distinct mechanisms of action of progesterone and selective progesterone receptor modulator on uterine leiomyomas
    Milewska, Gabriela
    Ponikwicka-Tyszko, Donata
    Bernaczyk, Piotr
    Lupu, Oana
    Szamatowicz, Michal
    Sztachelska, Maria
    Pilaszewicz-Puza, Agata
    Koda, Mariusz
    Bielawski, Tomasz
    Zbucka-Kretowska, Monika
    Pawelczyk, Adam
    Tomaszewski, Jakub
    Li, Xiangdong
    Huhtaniemi, Ilpo
    Wolczynski, Slawomir
    Rahman, Nafis A.
    FERTILITY AND STERILITY, 2024, 122 (02) : 341 - 351
  • [9] Markers of Inflammation and Vascular Parameters in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids
    Szydlowska, Iwona
    Grabowska, Marta
    Nawrocka-Rutkowska, Jolanta
    Kram, Andrzej
    Piasecka, Malgorzata
    Starczewski, Andrzej
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [10] EFFECTS OF PROGESTERONE RECEPTOR ON PROLIFERATION OF UTERINE LEIOMYOMA CELLS
    Liao, S.
    Mi, H. N.
    Chai, L. Y.
    Wang, H. N.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (06) : 1685 - 1693